| Shareholder | |||
|---|---|---|---|
| NG TitExecutive Director | 45.12% | 304.20M | |
| CHIN YuNon-Executive Director | 45.12% | 304.20M | |
| Ieong Chong Mang | 39.25% | 747.66M | |
| Shum Ning | 39.25% | 747.66M | |
| Ieong Iat | 21.73% | 146.52M | |
| NG TitExecutive Director | 21.39% | 407.39M | |
| CHIN YuNon-Executive Director | 21.39% | 407.39M | |
| CHEN HONGLI | 8.46% | 80.33M | |
| ZHANG GENHUO | 8.37% | 79.40M | |
| Ieong Chong Mang | 8.15% | 54.93M | |
| Shum Ning | 8.15% | 54.93M | |
| Lou YongbinNon-Executive Director | 6.43% | 61.07M |
Holders of 5% or more of the voting shares (long positions), from the HKEXnews Disclosure of Interests consolidated list of substantial shareholders; the report date is each holder's latest filing.
This page shows the major shareholders of NT PHARMA (01011) holding 5% or more, with stake, shares held and last filing date, and substantial shareholder disclosure-of-interest changes over the past year. Data comes from the HKEXnews Disclosure of Interests (DI) section.

